Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas - an immunohistochemical study

被引:41
作者
Habberstad, Andreas H. [1 ]
Gulati, Sasha [1 ,2 ]
Torp, Sverre H. [1 ,3 ]
机构
[1] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway
[2] St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway
[3] St Olavs Univ Hosp, Dept Pathol & Med Genet, Trondheim, Norway
关键词
HISTONE H3; PROGNOSTIC-SIGNIFICANCE; EXPRESSION; NUCLEAR; TUMORS; GRADE; INDEX; KI-67; PHOSPHORYLATION; APOPTOSIS;
D O I
10.1186/1746-1596-6-43
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Histological malignancy grading of astrocytomas can be challenging despite criteria given by the World Health Organisation (WHO). Grading is fundamental for optimal prognostication and treatment, and additional biomarkers are needed to support the histopathological diagnosis. Estimation of proliferative activity has gained much enthusiasm, and the present study was designed to evaluate and compare novel immunohistochemical proliferative markers in human anaplastic astrocytomas. Methods: Proliferative activity was determined in twenty-seven cases with antibodies reactive against the Ki-67 antigen, mitosin, survivin, pHH3, and DNA topoisomerase II alpha, and they were mutually compared as well as related to mitotic activity. Results: The markers correlated well with each other, but poorly with mitoses, probably because of small and squeezed tumour samples, in which identification of mitoses can be difficult. Positive association to overall survival was observed as well. Conclusions: Our data show that these markers may assist significantly in the evaluation of proliferative activity in anaplastic astrocytomas and even have prognostic value.
引用
收藏
页数:8
相关论文
共 32 条
[1]   High expression of DNA topoisomerase IIα and Ki-67 antigen is associated with prolonged survival glioblastoma patients [J].
Bredel, M ;
Piribauer, M ;
Marosi, C ;
Birner, P ;
Gatterbauer, B ;
Fischer, I ;
Ströbel, T ;
Rössler, K ;
Budka, H ;
Hainfellner, JA .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (10) :1343-1347
[2]   Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms [J].
Chakravarti, A ;
Zhai, GG ;
Zhang, M ;
Malhotra, R ;
Latham, DE ;
Delaney, MA ;
Robe, P ;
Nestler, U ;
Song, QH ;
Loeffler, J .
ONCOGENE, 2004, 23 (45) :7494-7506
[3]   Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas [J].
Colman, H ;
Giannini, C ;
Huang, L ;
Gonzalez, J ;
Hess, K ;
Britner, J ;
Fuller, G ;
Langford, L ;
Pelloski, C ;
Aaron, J ;
Burger, P ;
Aldape, K .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (05) :657-664
[4]   Expression of Ki-67, Topoisomerase IIα and c-MYC in astrocytic tumors:: Correlation with the histopathological grade and proliferative status [J].
Faria, Mario H. G. ;
Goncalves, Bronner P. A. ;
do Patrocinio, Regia M. do S. V. ;
De Moraes-Filho, Manoel O. ;
Rabenhorst, Silvia H. B. .
NEUROPATHOLOGY, 2006, 26 (06) :519-527
[5]   Cellular proliferation in pilocytic and diffuse astrocytomas [J].
Giannini, C ;
Scheithauer, BW ;
Burger, PC ;
Christensen, MR ;
Wollan, PC ;
Sebo, TJ ;
Forsyth, PA ;
Hayostek, CJ .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1999, 58 (01) :46-53
[6]   Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas [J].
Gulati, Sasha ;
Ytterhus, Borgny ;
Granli, Unn S. ;
Gulati, Michel ;
Lydersen, Stian ;
Torp, Sverre H. .
DIAGNOSTIC PATHOLOGY, 2010, 5
[7]   Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation [J].
Hendzel, MJ ;
Wei, Y ;
Mancini, MA ;
VanHooser, A ;
Ranalli, T ;
Brinkley, BR ;
BazettJones, DP ;
Allis, CD .
CHROMOSOMA, 1997, 106 (06) :348-360
[8]   MIB-1 and DNA topoisomerase IIα could be helpful for predicting long-term survival of patients with glioblastoma [J].
Ho, DMT ;
Hsu, CY ;
Ting, LT ;
Chiang, H .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 119 (05) :715-722
[9]   The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas [J].
Johannessen, Anne Linn ;
Torp, Sverre Helge .
PATHOLOGY & ONCOLOGY RESEARCH, 2006, 12 (03) :143-147
[10]  
Juan G, 1998, CYTOMETRY, V32, P71, DOI 10.1002/(SICI)1097-0320(19980601)32:2<71::AID-CYTO1>3.0.CO